Cao Jie, Zhu Xucheng, Liu Sheng, Zhang Yunfeng, Yin Congguo, Zhong Chongke, Mo Yi, Xuan Jinggang, Chen Ronghua, Zhou Chun, Huang Guoxiang, Xia Wenqing, Xing Wei, Peng Ya
Department of Neurosurgery, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Front Neurosci. 2024 Oct 8;18:1398749. doi: 10.3389/fnins.2024.1398749. eCollection 2024.
Endovascular recanalization is a feasible option for treating symptomatic non-acute middle cerebral artery occlusion (MCAO) patients. Hence, we aimed to establish a new angiographic scoring to grade the recanalization difficulty of MCAO to determine the suitable patients for endovascular treatment.
We retrospectively analyzed a total of 113 consecutive recurrent symptomatic non-acute MCAO patients who underwent endovascular recanalization from July 2015 to August 2021 in four Chinese comprehensive stroke centers. All patients were reappraised using a new angiographic scoring based on the stump morphology, the MCA occlusion length, MCA bend, and the distal vascular bed of MCAO. We used the final results to establish the patients' outcomes.
The total successful recanalization and perioperative complication rates were 83.2% (94/113) and 15.9% (18/113), respectively. No deaths occurred within 30 days. Moreover, 96.9, 90, 87.5, 52.6, and 50% of the patients achieved recanalization with scores of 0, 1, 2, 3, and 4 ( 0.001), respectively. However, the perioperative complication rate showed the opposite trend. (3.1% vs. 7.5% vs. 6.3% vs. 52.6% vs. 50%; < 0.001). The median time of successful microwire crossing of the occlusion lesion (TMO) in the score 0 group was shorter than the other groups (2 min, 9 min, 8.5 min, 14 min, and 20 min; < 0.001). When a score of 2 was used as the optimal cut-off point, the sensitivity and specificity were 86.2 and 63.2%, respectively.
The new angiographic scoring can effectively predict the successful recanalization rate, perioperative complication rate, and TMO of endovascular recanalization for non-acute MCAO. It can also be used as an effective clinical evaluation tool to determine the suitable non-acute MCAO patients for recanalization, especially with a score ≤ 2.
血管内再通术是治疗有症状的非急性大脑中动脉闭塞(MCAO)患者的一种可行选择。因此,我们旨在建立一种新的血管造影评分系统,以对MCAO的再通难度进行分级,从而确定适合进行血管内治疗的患者。
我们回顾性分析了2015年7月至2021年8月期间在中国四个综合卒中中心接受血管内再通术的113例连续复发性有症状的非急性MCAO患者。所有患者均使用基于残端形态、MCA闭塞长度、MCA弯曲度和MCAO远端血管床的新血管造影评分系统进行重新评估。我们用最终结果来确定患者的预后。
总的成功再通率和围手术期并发症发生率分别为83.2%(94/113)和15.9%(18/113)。30天内无死亡病例。此外,评分分别为0、1、2、3和4时,实现再通的患者比例分别为96.9%、90%、87.5%、52.6%和50%(P<0.001)。然而,围手术期并发症发生率呈现相反趋势(3.1%对7.5%对6.3%对52.6%对50%;P<0.001)。评分0组闭塞病变成功通过微导丝的中位时间短于其他组(2分钟、9分钟、8.5分钟、14分钟和20分钟;P<0.001)。以2分为最佳截断点时,敏感性和特异性分别为86.2%和63.2%。
新的血管造影评分系统能够有效预测非急性MCAO血管内再通术的成功再通率、围手术期并发症发生率和闭塞病变成功通过微导丝的时间。它还可作为一种有效的临床评估工具,用于确定适合进行再通术的非急性MCAO患者,尤其是评分≤2分的患者。